• 1
    Bailar JC, Hoaglin DC, eds. Medical Uses of Statistics, 3rd ed. Hoboken, NJ: John Wiley & Sons; 2009.
  • 2
    Turner JR. The 50th anniversary of the Kefauver-Harris Amendments: efficacy assessment and the randomized clinical trial. J Clin Hypertens (Greenwich). 2012;14:810815.
  • 3
    Turner JR, Hoofwijk TJ. Clinical trials in new drug development. J Clin Hypertens (Greenwich). 2013;15:306309.
  • 4
    Matthews JNS. Introduction to Randomized Controlled Clinical Trials, 2nd ed. Boca Raton, FL: Chapman & Hall/CRC; 2006.
  • 5
    Turner JR. New Drug Development: An Introduction to Clinical Trials, 2nd ed. New York, NY: Springer; 2010.
  • 6
    Turner JR. Editor's commentary: additional associate editors, new submission category, and meta-methodology. Drug Inf J. 2011;45:221227.
  • 7
    Turner JR, Satin LZ, Callahan T, Litwin J. The science of cardiac safety. Appl Clin Trials. 2010;19(11 suppl):48, 14.
  • 8
    Persu A, Jin Y, Azizi M, et al; on behalf of the European Network COordinating research on REnal Denervation (ENCOReD). Blood pressure changes after renal denervation at 10 European expert centers. J Hum Hypertens. 2013 Sep 26. [Epub ahead of print]
  • 9
    Durham TA, Turner JR. Introduction to Statistics in Pharmaceutical Clinical Trials. London: Pharmaceutical Press; 2008.
  • 10
    DiNicolantonio JJ, Lavie CJ, Fares H, et al. Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol). Am J Cardiol. 2013;111:765769.
  • 11
    Grassi G, Seravalle G, Brambilla G, Mancia G. The sympathetic nervous system and new nonpharmacologic approaches to treating hypertension: a focus on renal denervation. Can J Cardiol. 2012;28:311317.
  • 12
    Gosain P, Garimella PS, Hart PD, Agarwal R. Renal sympathetic denervation for treatment of resistant hypertension: a systematic review. J Clin Hypertens (Greenwich). 2013;15:7584.
  • 13
    Gulati V, White WB. Review of the state of renal nerve ablation for patients with severe and resistant hypertension. J Am Soc Hypertens. 2013Aug 14; [Epub ahead of print].
  • 14
    Doumas M, Anyfanti P, Bakris G. Should ambulatory blood pressure monitoring be mandatory for future studies in resistant hypertension: a perspective. J Hypertens. 2012;30:874876.
  • 15
    Turner JR, O'Brien E. Diagnosis and treatment of resistant hypertension: the critical role of ambulatory blood pressure monitoring. J Clin Hypertens (Greenwich). 2013;15:868873.